Stay updated with breaking news from Shanej schaffer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cingulate Inc. (NASDAQ: CING) shares weakened, as the drug company announced that it has received guidance from the Food and Drug Administration (FDA) on advancing its investigational asset CTx-2103 (buspirone) for the treatment of anxiety into clinical . ....
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone) sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cingulate to Host CNS Key Opinion Leader Panel in New York City streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.